Thompson worked for birth control maker

In his recent financial disclosure statement, filed last month, Thompson disclosed that he was a director of a company called Evofem from July 2005 until he resigned last month. Thompson also disclosed that he had been paid at least $5,000 by Evofem for consulting services. Evofem, according to its website, is developing technologies in the field of women's reproductive health. One of its drugs, Amphora, is being evaluated as a microbicide to protect women from pregnancy. (JOURNAL SENTINEL, 2/22)